BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31896942)

  • 1. Inter-laboratory proficiency testing scheme for tumour next-generation sequencing in Ontario: a pilot study.
    Spence T; Stickle N; Yu C; Chow H; Feilotter H; Lo B; McCready E; Sadikovic B; Siu LL; Bedard PL; Stockley TL
    Curr Oncol; 2019 Dec; 26(6):e717-e732. PubMed ID: 31896942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-laboratory proficiency testing of clinical cancer genomic profiling by next-generation sequencing.
    Zhong Q; Wagner U; Kurt H; Molinari F; Cathomas G; Komminoth P; Barman-Aksözen J; Schneider-Yin X; Rey JP; Vassella E; Rogel U; Diebold J; McKee T; Jochum W; Kashofer K; Hofman P; Zischka M; Moch H; Rechsteiner M; Wild PJ
    Pathol Res Pract; 2018 Jul; 214(7):957-963. PubMed ID: 29807778
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of the UK NEQAS for Molecular Genetics reference sample analysis.
    Richman SD; Fairley J; Hall JA; Nataraj N; Bhide M; Lau A; Norman KL; Deans ZC
    J Clin Pathol; 2018 Nov; 71(11):989-994. PubMed ID: 30030291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-Institutional FASTQ File Exchange as a Means of Proficiency Testing for Next-Generation Sequencing Bioinformatics and Variant Interpretation.
    Davies KD; Farooqi MS; Gruidl M; Hill CE; Woolworth-Hirschhorn J; Jones H; Jones KL; Magliocco A; Mitui M; O'Neill PH; O'Rourke R; Patel NM; Qin D; Ramos E; Rossi MR; Schneider TM; Smith GH; Zhang L; Park JY; Aisner DL
    J Mol Diagn; 2016 Jul; 18(4):572-9. PubMed ID: 27155050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Model Study of In Silico Proficiency Testing for Clinical Next-Generation Sequencing.
    Duncavage EJ; Abel HJ; Merker JD; Bodner JB; Zhao Q; Voelkerding KV; Pfeifer JD
    Arch Pathol Lab Med; 2016 Oct; 140(10):1085-91. PubMed ID: 27388684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cytocentrifugation supernatant fluid and formalin-fixed paraffin-embedded tissue for targeted next-generation sequencing.
    Janaki N; Harbhajanka A; Michael CW; Bomeisl P; Wasman J; Atchley M; Miskiewicz K; Alouani D; Sadri N
    Cancer Cytopathol; 2019 May; 127(5):297-305. PubMed ID: 30933438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Next-Generation Sequencing (NGS) Methods Show Superior or Equivalent Performance to Non-NGS Methods on
    Surrey LF; Oakley FD; Merker JD; Long TA; Vasalos P; Moncur JT; Kim AS
    Arch Pathol Lab Med; 2019 Aug; 143(8):980-984. PubMed ID: 30865489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Describing the Reportable Range Is Important for Reliable Treatment Decisions: A Multiple Laboratory Study for Molecular Tumor Profiling Using Next-Generation Sequencing.
    Tack V; Spans L; Schuuring E; Keppens C; Zwaenepoel K; Pauwels P; Van Houdt J; Dequeker EMC
    J Mol Diagn; 2018 Nov; 20(6):743-753. PubMed ID: 30055348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continual Improvement of the Reliability of Next-Generation Sequencing-Based ctDNA Analysis: A Long-Term Comparison of ctDNA Detection in China.
    Peng R; Zhang R; Li J
    Clin Chem; 2022 Jul; 68(7):940-952. PubMed ID: 35687601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of on-site evaluation as external quality assessment for ISO 15189 accreditation of laboratories performing next-generation sequencing oncology tests.
    Ravzanaadii M; Asai S; Kakizoe H; Natsagdorj ME; Miyachi H
    J Clin Lab Anal; 2023 May; 37(9-10):e24901. PubMed ID: 37272760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material.
    de Leng WW; Gadellaa-van Hooijdonk CG; Barendregt-Smouter FA; Koudijs MJ; Nijman I; Hinrichs JW; Cuppen E; van Lieshout S; Loberg RD; de Jonge M; Voest EE; de Weger RA; Steeghs N; Langenberg MH; Sleijfer S; Willems SM; Lolkema MP
    PLoS One; 2016; 11(2):e0149405. PubMed ID: 26919633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementation of next generation sequencing technology for somatic mutation detection in routine laboratory practice.
    Giardina T; Robinson C; Grieu-Iacopetta F; Millward M; Iacopetta B; Spagnolo D; Amanuel B
    Pathology; 2018 Jun; 50(4):389-401. PubMed ID: 29752127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.
    Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS; Lawson DH; Delman KA; El-Rayes BF; Wilson MM; Sullivan HC; Morrison AS; Balci S; Adsay NV; Gal AA; Sica GL; Saxe DF; Mann KP; Hill CE; Khuri FR; Rossi MR
    J Mol Diagn; 2016 Mar; 18(2):299-315. PubMed ID: 26801070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proficiency Testing of Standardized Samples Shows Very High Interlaboratory Agreement for Clinical Next-Generation Sequencing-Based Oncology Assays.
    Merker JD; Devereaux K; Iafrate AJ; Kamel-Reid S; Kim AS; Moncur JT; Montgomery SB; Nagarajan R; Portier BP; Routbort MJ; Smail C; Surrey LF; Vasalos P; Lazar AJ; Lindeman NI
    Arch Pathol Lab Med; 2019 Apr; 143(4):463-471. PubMed ID: 30376374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective quality management practices in routine clinical next-generation sequencing.
    de Abreu FB; Peterson JD; Amos CI; Wells WA; Tsongalis GJ
    Clin Chem Lab Med; 2016 May; 54(5):761-71. PubMed ID: 26872315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variant call concordance between two laboratory-developed, solid tumor targeted genomic profiling assays using distinct workflows and sequencing instruments.
    Hampel KJ; de Abreu FB; Sidiropoulos N; Peterson JD; Tsongalis GJ
    Exp Mol Pathol; 2017 Apr; 102(2):215-218. PubMed ID: 28192086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of the Oncomine
    Williams HL; Walsh K; Diamond A; Oniscu A; Deans ZC
    Virchows Arch; 2018 Oct; 473(4):489-503. PubMed ID: 30105577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Testing for Tumor Cell-Free DNA: College of American Pathologists Proficiency Programs Reveal Practice Trends.
    Devereaux KA; Souers RJ; Merker JD; Lindeman NI; Graham RP; Hameed MR; Vasalos P; Moncur JT; Lockwood CM; Xian RR
    Arch Pathol Lab Med; 2023 Apr; 147(4):425-433. PubMed ID: 35687785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Overview of Characteristics of Clinical Next-Generation Sequencing-Based Testing for Hematologic Malignancies.
    Zhang BM; Keegan A; Li P; Lindeman NI; Nagarajan R; Routbort MJ; Vasalos P; Kim AS; Merker JD
    Arch Pathol Lab Med; 2021 Sep; 145(9):1110-1116. PubMed ID: 33450747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality metrics for enhanced performance of an NGS panel using single-vial amplification technology.
    Barua S; Hsiao S; Clancy E; Freeman C; Mansukhani M; Fernandes H
    J Clin Pathol; 2023 Dec; 77(1):46-53. PubMed ID: 36376073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.